James M. Mock - May 27, 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Financial Officer
Signature
/s/ James Dillon, As Attorney-in-Fact
Stock symbol
MRNA
Transactions as of
May 27, 2025
Transactions value $
-$14,076
Form type
4
Date filed
5/29/2025, 05:16 PM
Previous filing
Apr 7, 2025
Next filing
Jul 7, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mock James M Chief Financial Officer 325 BINNEY STREET, CAMBRIDGE /s/ James Dillon, As Attorney-in-Fact 2025-05-29 0001736359

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise +773 +4.95% 16.4K May 27, 2025 Direct F1
transaction MRNA Common Stock Tax liability -$9.82K -374 -2.28% $26.26 16K May 27, 2025 Direct F2
transaction MRNA Common Stock Options Exercise +328 +2.05% 16.4K May 28, 2025 Direct F1
transaction MRNA Common Stock Tax liability -$4.25K -159 -0.97% $26.76 16.2K May 28, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Restricted Stock Units Options Exercise $0 -773 -8.33% $0.00 8.51K May 27, 2025 Common Stock 773 Direct F1, F3
transaction MRNA Restricted Stock Units Options Exercise $0 -328 -12.47% $0.00 2.3K May 28, 2025 Common Stock 328 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F4 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.